{"image_url":null,"type":"rich","description":"\u4eca\u56de\u306f\u3001\u300cALLHAT\u300d\u300cEUROPA\u300d\u300cCAMELOT\u300d\u306e3\u3064\u306e\u8ad6\u6587\u3092\u7d39\u4ecb\u3057\u3066\u3044\u304d\u307e\u3059\u3002 \u307e\u305a\u306f\u300cALLHAT\u300d\u8a66\u9a13\u304b\u3089\u3002 Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAM\u2026","author_url":"https://blog.hatena.ne.jp/gacharinco/","author_name":"gacharinco","provider_name":"Hatena Blog","published":"2019-03-09 14:53:58","height":"190","categories":["\u9ad8\u8840\u5727"],"width":"100%","provider_url":"https://hatena.blog","blog_url":"https://www.rincos-journal.com/","version":"1.0","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fwww.rincos-journal.com%2Fentry%2F2019%2F03%2F09%2F145358\" title=\"\u9ad8\u8840\u5727\u306e\u6709\u540d\u8ad6\u6587\u3082\u308d\u3082\u308d\u30fc2(\u300cALLHAT\u300d\u300cEUROPA\u300d\u300cCAMELOT\u300d) - \u30ea\u30f3\u30b3&#39;s \u30b8\u30e3\u30fc\u30ca\u30eb\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","title":"\u9ad8\u8840\u5727\u306e\u6709\u540d\u8ad6\u6587\u3082\u308d\u3082\u308d\u30fc2(\u300cALLHAT\u300d\u300cEUROPA\u300d\u300cCAMELOT\u300d)","blog_title":"\u30ea\u30f3\u30b3's \u30b8\u30e3\u30fc\u30ca\u30eb","url":"https://www.rincos-journal.com/entry/2019/03/09/145358"}